At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
THRD Third Harmonic Bio, Inc.
Trading 04-01 11:57:58 EDT
3.44
-0.03
-0.72%
| High3.46 | Low3.39 | Vol65.64K |
| Open3.46 | D1 Closing3.47 | Amplitude2.02% |
| Mkt Cap155.38M | Tradable Cap44.87M | Total Shares45.10M |
| T/O225.06K | T/O Rate0.50% | Tradable Shares13.02M |
| P/B0.54 | ROE-16.41% | EPS-1.09 |
| 52wk High16.94 | 52wk Low3.18 | P/E-3.16 |
| Dividend0.00 | Div.Yield0.00 | ROA-12.86% |
Third Harmonic Bio Cut to Hold From Buy by Stifel
Dow Jones · 03-28
Stifel Nicolaus Downgrades Third Harmonic Bio to Neutral From Buy, Adjusts Price Target to $5 From $23
MT Newswires Live · 03-28
Third Harmonic Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Reuters · 03-27
Third Harmonic Bio FY 2024 GAAP EPS $(1.09) Beats $(1.18) Estimate
Benzinga · 03-27
BRIEF-Third Harmonic Bio Q4 Net Income USD -13.1 Million
Reuters · 03-27
Third Harmonic Bio initiates process to identify opportunities to maximize value
TIPRANKS · 03-27
Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results
THOMSON REUTERS · 03-27
Third Harmonic Bio Inc - Strategic Alternatives Process Underway to Maximize Value Creation
THOMSON REUTERS · 03-27
Third Harmonic Bio Q4 Net Income USD -13.1 Million
THOMSON REUTERS · 03-27
Press Release: Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results
Dow Jones · 03-27
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones · 03-24
Third Harmonic Bio Inc expected to post a loss of 34 cents a share - Earnings Preview
Reuters · 03-21
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones · 03-20
Third Harmonic Bio, Inc. (THRD) Loses -31.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks · 03-04
Third Harmonic Bio, Inc. (THRD) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · 02-14
Down -39.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Third Harmonic Bio, Inc. (THRD)
Zacks · 02-14
Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape
Benzinga · 02-12
Morgan Stanley Downgrades Third Harmonic Bio to Equalweight From Overweight, Cuts Price Target to $5 From $20
MT Newswires Live · 02-12
Third Harmonic Bio, Inc.: Hold Rating Amid Strategic Uncertainty and Safety Concerns
TIPRANKS · 02-11
Third Harmonic Bio Cut to Market Perform From Outperform by Raymond James
Dow Jones · 02-11
Introduction
Company Name.
Third Harmonic Bio, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
2022-09-15
Main Business:
Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Issue price:
17.00
Invest in Global Markets with Tiger Brokers!Open App